Xylem (XYL) Stock Analysis & AI Equity Report

Industrial - Capital Goods USD Explore free reports

Xylem (XYL) overview

Xylem (XYL) stock analysis and AI equity research. For financial year 2025, Valuatum's model shows revenue of USD 9,035m and operating profit of USD 1,223m; the year-end share price was 136.18 USD and market capitalisation was USD 33,173m. Xylem is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get Xylem's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.

Key metrics & valuation multiples

Book valueUSD 11,480mFY 2025
Share price136.18 USDFY 2025 year end
RevenueUSD 9,035mFY 2025
Operating profitUSD 1,223mFY 2025
Net earningsUSD 957mFY 2025
Market capitalisationUSD 33,173mFY 2025 year end

About Xylem

Xylem designs, manufactures and services engineered products and solutions for water applications. Its portfolio supports drinking water delivery, treatment, measurement and use, as well as wastewater collection, testing, analysis and treatment. Offerings include transport and dewatering equipment, process water and wastewater treatment, analytics, smart metering, digital software and services. Customers include water utilities and other users across the water cycle.

Generate the Xylem report

Xylem is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.

Generate fresh report — €50.00 Delivered by email, usually within an hour

Sources & methodology

Financial figures are sourced from Valuatum's financial model for Xylem and represent financial year 2025. See the methodology for the full Valuatum AI equity research framework.

Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.

Analyst reports on Xylem

Each report here is this company's Valuatum report re-run with an analyst's own assumptions and published under their name. They are ordered by a score out of five: what other analysts felt the work added over the engine's default report.